Tag: Drugs: Misc.
Rahul Gupta to Be Nominated as Next U.S. Drug Czar
Gupta was the former health commissioner of West Virginia and is chief medical and health officer for the March of Dimes
Buprenorphine Rx Activity Varies Widely Among Clinicians
Less than 5 percent of prescribers account for half of all buprenorphine treatment in the country
Certain HTN Meds May Cut Deaths From Influenza, Pneumonia
Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia
September 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2020. This roundup includes the latest...
2009 to 2019 Saw Increase in Exposure to Phenibut in U.S.
Exposure resulted in moderate effects in 49.6 percent of cases and major effects in 12.6 percent
August 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for August 2020. This roundup includes the latest...
July 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for July 2020. This roundup includes the latest...
April 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2020. This roundup includes the latest...
FDA Issues Emergency Use Authorization for Remdesivir
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
Remdesivir May Accelerate Recovery From Severe COVID-19
Early results from NIH study promising, but Lancet study did not show significant clinical benefit
